Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Osteosarcoma × Drug Therapy × Clear all

Status

Unknown 5 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 9 Stomach Neoplasms 8 Small Cell Lung Carcinoma 6 Breast Neoplasms 6 Rectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Muscle-invasive Bladder Cancer 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Urologic Neoplasms 1 Thymus Neoplasms 1 Resectable Non-small Cell Lung Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Cancer Metastatic 1 Pancreatic Cancer Liver Metastases 1

Interventions

Ifosfamide 2 Etoposide 2 Cyclophosphamide 2 surufatinib 1 fludarabine 1 envafolimab 1 anlotinib 1 Vincristine 1 Topotecan 1 Positron Emission Tomography Computed Tomography 1 Neoadjuvant Therapy 1 Methotrexate 1 Mesna 1 Epirubicin 1 Eflornithine 1 Drug Therapy 1 Doxorubicin 1 Cisplatin 1 Brachytherapy 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06776198 2025-01-24

PTMTO

Peking University People's Hospital

Not yet recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡